Histamine H2 Receptor Polymorphisms, Myocardial Transcripts, and Heart Failure (from the Multi-Ethnic Study of Atherosclerosis and Beta-Blocker Effect on Remodeling and Gene Expression Trial)
- PMID: 29191567
- PMCID: PMC5742297
- DOI: 10.1016/j.amjcard.2017.10.016
Histamine H2 Receptor Polymorphisms, Myocardial Transcripts, and Heart Failure (from the Multi-Ethnic Study of Atherosclerosis and Beta-Blocker Effect on Remodeling and Gene Expression Trial)
Abstract
Myocardial H2 receptor activation contributes to heart failure (HF) in preclinical models, and H2 receptor antagonists are associated with decreased HF incidence. This study evaluated whether H2 histamine receptor (HRH2) single nucleotide polymorphisms (SNPs) are associated with HF incidence and whether myocardial transcript abundance is associated with HF recovery. The association of SNPs in HRH2 with incident HF was characterized using Cox proportional hazards regression among participants in the Multi-Ethnic Study of Atherosclerosis. Differences in myocardial HRH2 transcripts were characterized in participants with dilated cardiomyopathy comparing 6 "super-responders" with 6 nonresponders to β blockade in the Beta-Blocker Effect on Remodeling and Gene Expression Trial. In MESA, no candidate SNP was associated with HF in black, Hispanic, or white participants. The rs2241562 minor allele was present only in Chinese participants and the adjusted HF hazard among those with 1 or more copies of this allele was 3.7, 95% confidence interval 1.0 to 13.4. In BORG, super-responders to β blockade had higher levels of myocardial HRH2 transcript at baseline compared with nonresponders (fragments per kilobase per transcript per million mapped reads: Variant 2, 5.5 ± 1.1 compared with 3.2 ± 0.8 in nonresponders, p = 0.002; Variant 1 + 2, 32.1 ± 7.4 compared with 23.3 ± 4.2 in nonresponders, p = 0.04). In conclusion, the presence of a minor allele at rs2241562 was associated with increased HF incidence in Chinese participants. Differences in myocardial HRH2 transcript abundance were seen in participants with dilated cardiomyopathy who responded to β blockade. These observations support the hypothesis that HRH2 is involved in the pathogenesis of HF.
Copyright © 2017 Elsevier Inc. All rights reserved.
Conflict of interest statement
Figures
Similar articles
-
Association of genome-wide variation with the risk of incident heart failure in adults of European and African ancestry: a prospective meta-analysis from the cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium.Circ Cardiovasc Genet. 2010 Jun;3(3):256-66. doi: 10.1161/CIRCGENETICS.109.895763. Epub 2010 May 5. Circ Cardiovasc Genet. 2010. PMID: 20445134 Free PMC article.
-
Histamine H2 Receptor Antagonists, Left Ventricular Morphology, and Heart Failure Risk: The MESA Study.J Am Coll Cardiol. 2016 Apr 5;67(13):1544-1552. doi: 10.1016/j.jacc.2016.01.045. J Am Coll Cardiol. 2016. PMID: 27150686 Free PMC article.
-
Associations of SNPs in ADIPOQ and subclinical cardiovascular disease in the multi-ethnic study of atherosclerosis (MESA).Obesity (Silver Spring). 2011 Apr;19(4):840-7. doi: 10.1038/oby.2010.229. Epub 2010 Oct 7. Obesity (Silver Spring). 2011. PMID: 20930713 Free PMC article.
-
Beta-blocker pharmacogenetics in heart failure.Heart Fail Rev. 2010 May;15(3):187-96. doi: 10.1007/s10741-008-9094-x. Epub 2008 Apr 24. Heart Fail Rev. 2010. PMID: 18437562 Free PMC article. Review.
-
Genomics, transcriptional profiling, and heart failure.J Am Coll Cardiol. 2009 May 12;53(19):1752-9. doi: 10.1016/j.jacc.2008.12.064. J Am Coll Cardiol. 2009. PMID: 19422981 Free PMC article. Review.
Cited by
-
The Roles of Cardiovascular H2-Histamine Receptors Under Normal and Pathophysiological Conditions.Front Pharmacol. 2021 Dec 20;12:732842. doi: 10.3389/fphar.2021.732842. eCollection 2021. Front Pharmacol. 2021. PMID: 34987383 Free PMC article. Review.
-
Does Cell-Type-Specific Silencing of Monoamine Oxidase B Interfere with the Development of Right Ventricle (RV) Hypertrophy or Right Ventricle Failure in Pulmonary Hypertension?Int J Mol Sci. 2024 Jun 5;25(11):6212. doi: 10.3390/ijms25116212. Int J Mol Sci. 2024. PMID: 38892401 Free PMC article.
-
Associations of Histamine Metabolites with Disease Severity and Mortality in Pulmonary Arterial Hypertension.Ann Am Thorac Soc. 2023 Nov;20(11):1676-1679. doi: 10.1513/AnnalsATS.202304-302RL. Ann Am Thorac Soc. 2023. PMID: 37668470 Free PMC article. No abstract available.
-
Sequential analysis of myocardial gene expression with phenotypic change: Use of cross-platform concordance to strengthen biologic relevance.PLoS One. 2019 Aug 30;14(8):e0221519. doi: 10.1371/journal.pone.0221519. eCollection 2019. PLoS One. 2019. PMID: 31469842 Free PMC article.
-
Label-Free Investigations on the G Protein Dependent Signaling Pathways of Histamine Receptors.Int J Mol Sci. 2021 Sep 9;22(18):9739. doi: 10.3390/ijms22189739. Int J Mol Sci. 2021. PMID: 34575903 Free PMC article.
References
-
- Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR, Greenland P, Jacob DR, Kronmal R, Liu K, Nelson JC, O’Leary D, Saad MF, Shea S, Szklo M, Tracy RP. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol. 2002;156:871–881. - PubMed
-
- MESA Manual of Operations: Field Center and Laboratory Procedures. mesa-nhlbiorg. Available at: http://www.mesa-nhlbi.org/manuals.aspx. Accessed March 17, 2014.
Publication types
MeSH terms
Substances
Grants and funding
- HHSN268201500003C/HL/NHLBI NIH HHS/United States
- N01 HC095168/HL/NHLBI NIH HHS/United States
- L30 HL110124/HL/NHLBI NIH HHS/United States
- N01 HC095167/HC/NHLBI NIH HHS/United States
- N01 HC095161/HC/NHLBI NIH HHS/United States
- N01 HC095167/HL/NHLBI NIH HHS/United States
- N01 HC095159/HL/NHLBI NIH HHS/United States
- P30 DK063491/DK/NIDDK NIH HHS/United States
- N01 HC095163/HL/NHLBI NIH HHS/United States
- KL2 TR002317/TR/NCATS NIH HHS/United States
- N01 HC095168/HC/NHLBI NIH HHS/United States
- UL1 TR000040/TR/NCATS NIH HHS/United States
- R01 HL048013/HL/NHLBI NIH HHS/United States
- K08 HL125725/HL/NHLBI NIH HHS/United States
- N01 HC095161/HL/NHLBI NIH HHS/United States
- UL1 TR001079/TR/NCATS NIH HHS/United States
- N01 HC095169/HL/NHLBI NIH HHS/United States
- N01 HC065226/HC/NHLBI NIH HHS/United States
- T32 HL007822/HL/NHLBI NIH HHS/United States
- N01 HC095164/HC/NHLBI NIH HHS/United States
- N01 HC095166/HC/NHLBI NIH HHS/United States
- N01 HC095160/HC/NHLBI NIH HHS/United States
- N01 HC095169/HC/NHLBI NIH HHS/United States
- UL1 TR001420/TR/NCATS NIH HHS/United States
- N01 HC095165/HC/NHLBI NIH HHS/United States
- HHSN268201500003I/HL/NHLBI NIH HHS/United States
- N01 HC095166/HL/NHLBI NIH HHS/United States
- KL2 TR000421/TR/NCATS NIH HHS/United States
- N01 HC095163/HC/NHLBI NIH HHS/United States
- N01 HC095162/HL/NHLBI NIH HHS/United States
- R01 HL071118/HL/NHLBI NIH HHS/United States
- UL1 TR001881/TR/NCATS NIH HHS/United States
- N01 HC095162/HC/NHLBI NIH HHS/United States
- N01 HC065226/HL/NHLBI NIH HHS/United States
- N01 HC095165/HL/NHLBI NIH HHS/United States
- N01 HC095164/HL/NHLBI NIH HHS/United States
- N01 HC095159/HC/NHLBI NIH HHS/United States
- N01 HC095160/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous